Skip to main content
. Author manuscript; available in PMC: 2021 May 1.
Published in final edited form as: Clin Gastroenterol Hepatol. 2019 Nov 6;18(5):1070–1081.e5. doi: 10.1016/j.cgh.2019.10.048

Table 2:

Trends in nutritional biomarkers over five years after gastric bypass or sleeve gastrectomy surgery in adolescents.

Baseline 6 months Year 1 Year 2 Year 3 Year 4 Year 5 P-value for comparison of values between visits
Nutritional biomarker Median* Median* Median* Median* Media* Median* Median* Baseline to 1y 1y to 5y linear trend Baseline to 5y
BMI (kg/m2)
Gastric Bypass 52.9
(45.8, 59.9)
N=161
39.4
(32.8, 46.3)
N=143
35.8
(30.6, 42.7)
N=144
35.5
(30.5, 44.0)
N=135
36.4
(30.4, 44.9)
N=130
37.5
(31.6, 43.2)
N=129
39.0
(32.0, 48.2)
N=134
<0.0001 0.002 <0.0001
Sleeve Gastrectomy 48.0
(45.1, 52.9)
N=65
35.8
(32.5, 39.7)
N=53
33.7
(29.7, 37.7)
N=58
33.7
(29.3, 38.1)
N=51
34.7
(29.5, 40.3)
N=45
34.7
(30.9, 39.8)
N=51
37.0
(32.1, 40.8)
N=49
<0.0001 0.008 <0.0001
Ferritin (ug/L)
Gastric Bypass 39.0
(24.5, 72.0)
N=160
27.0
(15.0, 48.5)
N=136
18.5
(9.0, 31.0)
N=142
9.0
(6.0, 20.0)
N=132
8.0
(4.0, 16.0)
N=129
7.0
(4.0, 15.0)
N=120
6.0
(4.0, 13.0)
N=122
<0.0001 <0.0001 <0.0001
Sleeve Gastrectomy 30.0
(18.0, 52.0)
N=63
36.0
(15.5, 60.0)
N=52
27.0
(12.0, 54.0)
N=55
23.0
(9.0, 37.0)
N=49
18.0
(9.0, 33.5)
N=44
14.0
(6.0, 37.0)
N=49
12.0
(7.0, 29.0)
N=42
ns
0.98
0.0002 0.002
Transferrin (mg/mL)
Gastric Bypass 266
(245, 290)
N=160
280
(250, 302)
N=136
284
(257, 329)
N=142
308
(278, 350)
N=132
326
(292, 362)
N=129
332
(298, 372)
N=120
330
(307, 367)
N=122
0.0008 <0.0001 <0.0001
Sleeve Gastrectomy 274
(242, 307)
N=63
263
(233, 305)
N=51
277
(239, 308)
N=55
277
(249, 314)
N=49
281
(250, 324)
N=44
291
(267, 324)
N=49
304
(266, 345)
N=42
ns
0.99
0.0006 ns
0.09
Vitamin B12 (pg/mL)
Gastric Bypass 411
(305, 571)
N=159
356
(262, 537)
N=136
318
(207, 519)
N=142
282
(198, 426)
N=132
286
(188, 387)
N=129
251
(174, 408)
N=120
268
(183, 390)
N=122
ns
0.06
0.01 <0.0001
Sleeve Gastrectomy 525
(382, 722)
N=63
417
(268, 517)
N=52
330
(233, 497)
N=55
384
(238, 527)
N=49
378
(240, 504)
N=44
336
(245, 484)
N=49
396
(267, 579)
N=42
0.004 ns
0.41
ns
0.35
Vitamin B1 (erythrocyte transketolase activity coefficient)
Gastric Bypass 1.0
(1.0, 1.07)
N=154
1.00
(1.00, 1.06)
N=133
1.01
(1.00, 1.08)
N=137
1.00
(1.00, 1.07)
N=126
1.01
(1.00, 1.08)
N=127
1.00
(1.00, 1.09)
N=116
1.00
(1.00, 1.05)
N=113
ns
0.67
0.04 ns
0.99
Sleeve Gastrectomy 1.00
(1.00, 1.07)
N=61
1.02
(1.00, 1.12)
N=51
1.00
(1.00, 1.10)
N=56
1.00
(1.00, 1.08)
N=48
1.00
(1.00, 1.10)
N=44
1.00
(1.00, 1.04)
N=43
1.00
(1.00, 1.04)
N=39
ns
0.99
ns
0.07
ns
0.83
Folate (ug/mL)
Gastric Bypass 14.2
(10.7, 18.9)
N=158
11.2
(6.9, 17.4)
N=136
13.2
(8.2, 18.9)
N=142
13.7
(9.9, 17.8)
N=131
14.2
(10.4, 20.0)
N=129
15.0
(11.8, 22.0)
N=120
17.0
(11.9, 22.0)
N=122
ns
0.60
<0.0001 0.03
Sleeve Gastrectomy 17.4
(11.7, 20.0)
N=62
11.6
(6.8, 18.4)
N=52
11.2
(6.3, 20.0)
N=54
13.0
(9.3, 20.4)
N=49
11.8
(9.5, 22.0)
N=44
14.1
(9.8, 21.4)
N=48
13.6
(9.7, 17.9)
N=42
0.03 ns
0.12
ns
0.75
Vitamin A (ug/L)
Gastric Bypass 430
(370, 515)
N=158
382
(313, 466)
N=134
400
(327, 487)
N=142
402
(330, 507)
N=131
393
(331, 488)
N=127
396
(312, 484)
N=120
386
(336, 479)
N=121
ns
0.85
ns
0.31
ns
0.38
Sleeve Gastrectomy 436
(369, 508)
N=61
398
(362, 505)
N=50
422
(370, 474)
N=55
419
(362, 487)
N=48
429
(362, 512)
N=44
425
(361, 500)
N=49
453
(393, 520)
N=43
ns
0.99
ns
0.58
ns
0.99
25-OH Vitamin D (ng/mL)
Gastric Bypass 21.4
(15.5, 28.0)
N=159
24.8
(17.4, 32.2)
N=134
23.4
(17.0, 31.4)
N=142
20.5
(14.0, 29.6)
N=131
20.2
(13.1, 26.8)
N=129
19.3
(13.6, 28.4)
N=120
19.7
(12.5, 27.6)
N=119
ns
0.22
0.02 ns
1.00
Sleeve Gastrectomy 25.0
(21.2, 32.7)
[N=62
26.6
(22.2, 36.3)
N=51
27.1
(20.2, 35.8)
N=55
23.0
(17.7, 29.4)
N=49
22.8
(18.3, 28.6)
[N=44
22.6
(17.8, 25.8)
N=48
23.2
(16.9, 29.1)
N=42
ns
0.99
0.008 ns
0.41
PTH (pg/mL)
Gastric Bypass 44.0
(34.0, 63.0)
N=159
41.0
(32.0, 50.0)
N=135
46.0
(34.0, 58.0)
N=142
51.0
(41.0, 65.0)
N=131
54.0
(41.0, 72.0)
N=129
57.0
(40.0, 75.0)
N=118
59.0
(44.0, 72.0)
N=122
ns
0.99
<0.0001 0.0002
Sleeve Gastrectomy 37.5
(27.0, 47.0)
N=62
31.0
(25.0, 37.0)
N=62
32.0
(28.0, 52.0)
N=55
37.0
(30.0, 43.0)
N=49
33.5
(27.5, 44.5)
N=44
40.0
(29.0, 53.0)
N=47
37.0
(32.0, 45.0)
N=41
ns
0.99
ns
0.52
ns
0.94
Albumin (g/dL)
Gastric Bypass 4.1
(3.9, 4.3)
N=160
4.2
(4.0, 4.4)
N=138
4.2
(4.0, 4.4)
N=142
4.3
(4.1, 4.5)
N=133
4.3
(4.1, 4.5)
N=128
4.2
(4.0, 4.5)
N=122
4.2
(4.1, 4.4)
N=122
0.003 ns
0.76
0.03
Sleeve Gastrectomy 4.3
(4.0, 4.5)
[N=63
4.3
(4.1, 4.5)
N=52
4.3
(4.1, 4.6)
N=55
4.4
(4.1, 4.5)
N=49
4.2
(4.0, 4.4)
N=44
4.3
(4.1, 4.5)
N=49
4.3
(4.0, 4.6)
N=44
ns
0.98
ns
0.11
ns
1.00
hs-CRP (mg/dL)
Gastric Bypass 0.65
(0.32, 1.20)
N=160
0.22
(0.08, 0.55)
N=137
0.09
(0.04, 0.29)
N=142
0.06
(0.03, 0.24)
N=131
0.08
(0.03, 0.19)
N=129
0.07
(0.02, 0.38)
N=121
0.12
(0.05, 0.36)
N=121
<0.0001 ns
0.40
<0.0001
Sleeve Gastrectomy 0.45
(0.19, 0.85)
N=63
0.14
(0.06, 0.47)
N=52
0.09
(0.03, 0.45)
N=55
0.05
(0.03, 0.12)
N=49
0.16
(0.04, 0.50)
N=44
0.11
(0.04, 0.34)
[N=49
0.09
(0.05, 0.63)
N=43
0.001 ns
0.06
0.01
*

Median (25th, 75th percentile)

P-values are from generalized linear mixed models performed using log transformed (ferritin, B12, PTH, hs-CRP) or untransformed data (all others). Tukey-Kramer adjustment used when testing differences between baseline and year 1 and baseline and year 5 time-points. A linear model was fitted to test for trend between year 1 and year 5.